Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis - PubMed (original) (raw)

Review

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis

J R MacDougall et al. Cancer Metastasis Rev. 1995 Dec.

Abstract

The malignant progression of tumors is driven by the expression of oncogenes and loss of expression of tumor suppressor genes; factors that are intrinsic to cancer cells. The phenotypic changes brought about by the gain or loss of expression of oncogenes and tumor suppressor genes lead to the acquisition of malignant traits, namely, the ability to invade into and grow in ectopic tissue environments. Recently, however, focus in cancer research has widened from the cancer cell to include the surrounding tumor stroma as an integral player in the process of tumor progression. One of the areas in cancer research contributing to this enhanced appreciation of stromal involvement in tumor progression and metastasis is that of matrix metalloproteinases (MMPs). This review provides an overview of the characteristics of MMPs and discusses their role in the progression and metastasis of tumors. Initially, attention will focus on the regulation of MMPs in tumor cells but will switch to discourse on stromal expression of MMPs in tumors and speculation on the functional consequences of stromal expression of MMPs.

PubMed Disclaimer

Similar articles

• Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.
  Crawford HC, Matrisian LM. Crawford HC, et al. Invasion Metastasis. 1994-1995;14(1-6):234-45. Invasion Metastasis. 1994. PMID: 7657516 Review.
• Matrix-degrading metalloproteinases in tumor progression.
  Matrisian LM, Wright J, Newell K, Witty JP. Matrisian LM, et al. Princess Takamatsu Symp. 1994;24:152-61. Princess Takamatsu Symp. 1994. PMID: 8983072 Review.
• Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
  Jodele S, Blavier L, Yoon JM, DeClerck YA. Jodele S, et al. Cancer Metastasis Rev. 2006 Mar;25(1):35-43. doi: 10.1007/s10555-006-7887-8. Cancer Metastasis Rev. 2006. PMID: 16680570 Review.
• Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications.
  Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P, Bellocq JP, Rio MC. Basset P, et al. Matrix Biol. 1997 Mar;15(8-9):535-41. doi: 10.1016/s0945-053x(97)90028-7. Matrix Biol. 1997. PMID: 9138286 Review.
• Tumour invasion and matrix metalloproteinases.
  Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P. Polette M, et al. Crit Rev Oncol Hematol. 2004 Mar;49(3):179-86. doi: 10.1016/j.critrevonc.2003.10.008. Crit Rev Oncol Hematol. 2004. PMID: 15036258 Review.

Cited by

• A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation.
  Jiménez MJ, Balbín M, Alvarez J, Komori T, Bianco P, Holmbeck K, Birkedal-Hansen H, López JM, López-Otín C. Jiménez MJ, et al. J Cell Biol. 2001 Dec 24;155(7):1333-44. doi: 10.1083/jcb.200106147. Epub 2001 Dec 17. J Cell Biol. 2001. PMID: 11748248 Free PMC article.
• Induction of matrix metalloprotease-7 is common in mucinous ovarian tumors including early stage disease.
  Shigemasa K, Tanimoto H, Sakata K, Nagai N, Parmley TH, Ohama K, O'Brien TJ. Shigemasa K, et al. Med Oncol. 2000 Feb;17(1):52-8. doi: 10.1007/BF02826217. Med Oncol. 2000. PMID: 10713661
• Proteolysis in human breast cancer.
  Garbett EA, Reed MW, Stephenson TJ, Brown NJ. Garbett EA, et al. Mol Pathol. 2000 Apr;53(2):99-106. doi: 10.1136/mp.53.2.99. Mol Pathol. 2000. PMID: 10889910 Free PMC article.
• Proteases and the biology of glioma invasion.
  Binder DK, Berger MS. Binder DK, et al. J Neurooncol. 2002 Jan;56(2):149-58. doi: 10.1023/a:1014566604005. J Neurooncol. 2002. PMID: 11995816 Review.
• Tumor-like coronary atheroma: a modern coronary evaluation with a historical perspective.
  Schwartz BG, Schussler JM, Rosenthal RL. Schwartz BG, et al. Tex Heart Inst J. 2011;38(3):275-8. Tex Heart Inst J. 2011. PMID: 21720471 Free PMC article. Review.

References

1. 1. Cancer Res. 1993 Jul 1;53(13):3154-8 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1962 Jun 15;48:1014-22 - PubMed
3. 1. J Cell Physiol. 1994 Jul;160(1):194-202 - PubMed
4. 1. Cancer Res. 1994 Sep 1;54(17):4791-7 - PubMed
5. 1. Mol Biol Cell. 1995 Jul;6(7):851-69 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database